Videos

RSS icon
Radiology Business management Association (RBMA) Co-executive directors Linda Wilgus, FRBMA, and Jessica Struve, CAE, share some of the highlights at the 2025 meeting.

Highlights from the 1st day of RBMA's annual meeting

Radiology Business Management Association Co-executive Directors Linda Wilgus and Jessica Struve share some of the highlights from the first day of the organization's annual meeting. 

Brian R. Lindman, MD, MSCI Medical Director, Structural Heart and Valve Center and associate professor of medicine, Vanderbilt University Medical Center, gives an update on the American Heart Association Target: Aortic Stenosis quality improvement program to catch more missing referrals.

AHA still working to find more patients with severe aortic stenosis who may require care

The initiative is designed to help identify more patients who may require aortic valve replacement. Brian Lindman, MD, provided an update on the project's efforts.

Laxmi Mehta explaining statins are no longer contraindicated for pregnant women

Is statin therapy safe for pregnant women?

Laxmi Mehta, MD, explained that the use of statins when treating pregnant women is no longer forbidden. However, she added, cardiologists should always discuss it first with their patients.

Video of Steven Bolling, MD, professor of cardiac surgery, University of Michigan, explaining trends in tricuspid valve repair and replacement at CRT 2025.

Key trends in transcatheter tricuspid valve interventions

Steven Bolling, MD, noted that tricuspid treatments have been linked to consistent benefits in terms of quality of life. However, he said, finding clear improvements in clinical outcomes has been more challenging.

Video of Laxmi Mehta, MD, The Ohio State University Wexner Medical Center, explaining the causes of cardiologist burnout and possible solutions. She spoke on this topic at AHA 2024.

How to address cardiologist burnout

Laxmi Mehta, MD, detailed several ways she and her colleagues at The Ohio State University are working to combat the rising levels of burnout among cardiologists.

S. Chris Malaisrie, MD, professor of surgery at Northwestern University Feinberg School of Medicine, and attending cardiac surgeon at the Bluhm Cardiovascular Institute of Northwestern Medicine, explains the late-breaking TAVR for failing bioprosthetic surgical valves five year outcomes from the PARTNER 3 Aortic Valve-in-Valve Registry at CRT 2025.

TAVR for failing surgical valves: Lessons learned from new 5-year data

S. Chris Malaisrie, MD, professor of surgery at Northwestern University, explained what these data can tell us about the lifetime management of patients who require aortic valve replacement.

Eric Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM, director of vascular intervention, Beth Israel Deaconess, section head, interventional cardiology and vascular research, Susan F. Smith Center for Outcomes Research, and associate professor of medicine, Harvard Medical School, explained some of the new bioresorbable stent scaffold technology that is being developed for use in PAD below the knee at CRT 2025.

Advances in bioresorbable stents show promise for treating PAD

Bioresorbable stents are back in the spotlight thanks to some significant progress from multiple medtech companies. Eric Secemsky, MD, discussed some of the biggest breakthroughs in this space at CRT 2025.

Video of Dave Dixon explaining the impact of first FDA approval of a generic DOAC.

FDA clears first generic versions of rivaroxaban—what it means for patient care

Dave Dixon, PharmD, explored the short- and long-term impact of these approvals, noting that they could help reduce costs down the line.

Displaying 57 - 64 of 526
Design by Adaptive Theme